Highlights GSK plc

Equities

GSK

GB00BN7SWP63

Pharmaceuticals

Market Closed - London S.E. Other stock markets 10:05:05 13/03/2026 pm IST			5-day change	1st Jan Change
2,031.00 ^GBX	0.00%		-0.34%	+11.32%

14/03	GSK and Amgen to add medicines to TrumpRx, Fox Business reports	RE
13/03	GSK plc Announces Expansion of AREXVY Approval to Adults Aged 18 to 49 Years for RSV Prevention	CI

Highlights

13/03	GSK plc Announces Expansion of AREXVY Approval to Adults Aged 18 to 49 Years for RSV Prevention	CI
13/03	Global markets live: Apple, Amazon, Nvidia, Uber, Adobe…
13/03	GSK Says US FDA Expands Arexvy Vaccine Approval to At-Risk Adults Under 50	MT
13/03	GSK Obtains US FDA's Nod to Expand Age Indication for RSV Vaccine	MT
13/03	GSK gets US FDA approval for expanded use of RSV vaccine	RE
13/03	GSK gets US FDA approval for Arexvy in adults between 18-49 at increased risk	RE
12/03	BioVersys AG Announces First Patient Dosed In Phase 2b Clinical Trial Of Alpe In Pulmonary Tuberculosis	CI
12/03	UI Boustead REIT falls in market debut after Singapore's biggest IPO this year	RE
11/03	FTSE 100 in the Red as US-Iran War Escalates; UK Commits to IEA Oil Stockpile Release	MT
11/03	AlphaValue/Baader Europe Upbeat on GSK Earnings Growth; Rating, Price Target Revised	MT
11/03	The Market Is Looking Suspiciously Calm
11/03	GSK's Wellcovorin Becomes First US FDA-approved Therapy for Cerebral Folate Deficiency	MT
10/03	US FDA Approves Expanded Use of GSK's Wellcovorin for Rare Neurological Condition	MT
10/03	Global markets live: Amazon, Meta, Goldman Sachs, OpenAI
10/03	US FDA approves leucovorin for rare genetic disorder causing autism-like symptoms	RE
10/03	Fda on March 9 approved expanded use of Gsk's Wellcovorin for treatment of cerebral folate deficiency among few adult & pediatric patients- website	RE
10/03	Story on leucovorin based on Washington Post report withdrawn	RE
10/03	Story and alerts on leucovorin based on Washington Post report withdrawn	RE
09/03	Global markets live: Live Nation, Eli Lilly, Amazon, Microsoft, ABB…
09/03	Gsk plc and Alfasigma S.P.A. Announce Agreement on Worldwide Rights for Linerixibat	CI
09/03	GSK and Alfasigma ink agreement for worldwide rights for linerixibat	AN
09/03	Astra drug wins US review as oil surges above USD100	AN
09/03	GSK Sells Rights to Drug Candidate to Alfasigma for Up to $690 Million	DJ
09/03	GSK Grants Global Rights for Investigational Cholestatic Pruritus Treatment to Alfasigma	MT
09/03	UK Stocks-Factors to watch on March 9	RE